AZIPRAL

Table of contents:

Trademark domain
nameis free?
azipral.com

The "AZIPRAL" trademark, serial number 78965319 , was filed on 31st of August 2006 with a mark drawing code of 4000 and its transaction date is 78965319. The attorney assigned is Bruce W. Longbottom, attorney docket number 15708. Since 18th of May 2010, the document can be found in the L10 law office in the publication and issue section. The employee responsible is LORENZO, GEORGE M and the date it was published for opposition on 01/23/2007. The status of the trademark was checked last on 05/17/2010.

Other trademarks by this attorney include , APLEVO . The corresponded responsible for this trademark is Bruce W. Longbottom, located at ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285-0001.

The state or country where the trademark was organized is IN by Eli Lilly And Company. The legal entity type behing it is a Corporation, located at Lilly Corporate Center, Indianapolis, IN zip 46285.Other trademarks by this applicant: APLEVO, ZELLETRA.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date09/07/2006
Primary Code005
Goods codes
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics and antidepressants
PROSECUTION HISTORY
DateDescriptionTypeCode
05/17/2010 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
05/17/2010 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
10/08/2009 EXTENSION 5 GRANTED S EX5G - EXTENSION 5 GRANTED
10/06/2009 EXTENSION 5 FILED S EXT5 - EXTENSION 5 FILED
10/06/2009 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
04/07/2009 EXTENSION 4 GRANTED S EX4G - EXTENSION 4 GRANTED
04/06/2009 EXTENSION 4 FILED S EXT4 - EXTENSION 4 FILED
04/06/2009 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
10/06/2008 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
10/02/2008 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
10/06/2008 CASE ASSIGNED TO INTENT TO USE PARALEGAL A - Allowance for Publication AITU
10/02/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
04/16/2008 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
04/02/2008 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
04/02/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
10/09/2007 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
09/25/2007 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
09/25/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
04/17/2007 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
01/23/2007 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
01/03/2007 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
12/05/2006 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
12/05/2006 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
11/16/2006 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2006 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
09/07/2006 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM

The "AZIPRAL" trademark, serial number 77947209 , was filed on 1st of March 2010 with a mark drawing code of 4000 and its transaction date is 77947209. Since 13th of April 2010, the document can be found in the L30 law office in the publication and issue section. The employee responsible is GILBERT, REBECCA L and the date it was published for opposition on 06/01/2010. The status of the trademark was checked last on 04/13/2010.

The corresponded responsible for this trademark is BRUCE W. LONGBOTTOM, located at ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN 46285-0001.

The state or country where the trademark was organized is IN by Eli Lilly And Company. The legal entity type behing it is a Corporation, located at Lilly Corporate Center, Indianapolis, IN zip 46285.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date03/04/2010
Primary Code005
Goods codes
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceutical preparations for use in the treatment of anxiety spectrum disorders, atherosclerosis and Alzheimer's; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders
PROSECUTION HISTORY
DateDescriptionTypeCode
03/04/2010 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM
04/13/2010 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2010 EXAMINER'S AMENDMENT ENTERED I - Incoming Correspondence XAEC - EXAMINER'S AMENDMENT ENTERED
04/13/2010 NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED O - Outgoing Correspondence GNEN
04/13/2010 EXAMINERS AMENDMENT E-MAILED F - First Action GNEA - EXAMINERS AMENDMENT E-MAILED
04/13/2010 EXAMINERS AMENDMENT -WRITTEN R - Renewal CNEA - EXAMINERS AMENDMENT -WRITTEN
04/12/2010 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
03/04/2010 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.